Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of VIMOVO in Adolescents with JIA
NCT01544114Phase 4Completed
- Sponsor
- Amgen
- Start
- Apr 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naproxen + esomeprazole in juvenile idiopathic arthritis (JIA), sponsored by Amgen. Started Apr 2012; status: completed.
02
Drugs
naproxen + esomeprazole
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT01544114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01544114.